<DOC>
	<DOCNO>NCT02950298</DOCNO>
	<brief_summary>The primary purpose study : - Document developmental outcome individual Pompe disease treat long-term enzyme-replacement therapy ( ERT ) school-age ( age 6-18 ) use measure cognitive functioning , academic skill , speech language ability . - Investigate possible cognitive processing speed weaknesses use BrainBaseline neurocognitive assessment software . - Investigate relationship behavior developmental factor include speech language ability cognitive ability . - Explore use select iPad application may help strengthen cognitive processing speed child Pompe disease</brief_summary>
	<brief_title>Pompe Telemedicine Developmental Study</brief_title>
	<detailed_description>The study last approximately 2-3 year . It include 2-4 visit Duke developmental assessment . The baseline/year 1 visit may take place Duke ( may take 1-2 day ) remotely via iPad . The follow 1/year 2 visit may take place Duke ( 1-2 day ) remotely via iPad , depend upon child 's particular situation .</detailed_description>
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<mesh_term>Glycogen Storage Disease</mesh_term>
	<criteria>Age range 618 year Diagnosis classic Pompe disease enzyme molecular method Patient , parent , legal guardian willing able give write informed consent English speaking child care giver .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pompe</keyword>
	<keyword>Glycogen Storage Disease II</keyword>
	<keyword>Telemedicine</keyword>
	<keyword>Duke University Medical Center</keyword>
</DOC>